CTOs on the Move

Angel Attic Community Inc

www.atticangel.org

 
Angel Attic Community Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Angel Attic Community Inc is based in Middleton, WI. You can find more information on Angel Attic Community Inc at www.atticangel.org
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Integrated Engineering Services

Integrated Engineering Services is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gateway Learning Group

At Gateway Learning Group, we cultivate learning, language, behavior and social skills for individuals with Autism and other special needs. Using the principles of Applied Behavior Analysis (ABA) we design and implement an individualized therapy program for each child based on his or her particular needs and interests. Our therapists are experienced in a full range of the best treatments available including Verbal Behavior, Pivotal Response Treatments, Discrete Trial Training, and the Early Start Denver Model. To provide comprehensive support for our clients and their families, we also collaborate with educators and health professionals. Most of all, we love working with each child and enjoy sharing in their sense of pride, joy and accomplishment as they succeed.

Granite YMCA

We create a community where all are welcome, with a focus on youth development, healthy living, social responsibility, and family strengthening.

WellDyneRX

WellDyneRx is a full-service, national pharmacy benefit manager (PBM) that makes the little things matter for our clients, employees, partners, and members.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.